Luca Spiezia
Overview
Explore the profile of Luca Spiezia including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
145
Citations
1825
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Vergadoro M, Spiezia L, Zanetto A, Zola E, Simioni P
Alcohol Alcohol
. 2025 Mar;
60(2).
PMID: 40052444
Aims And Methods: Hazardous alcohol use poses an increasing public health issue worldwide and it manifests as excessive consumption (acute or chronic), which may lead to addiction. The risk of...
2.
Napolitano A, Spiezia L, Biolo M, Radu C, Toffanin S, Campello E, et al.
Semin Thromb Hemost
. 2025 Jan;
PMID: 39884292
Anti-platelet factor 4 (PF4) antibody-mediated disorders are a heterogeneous group of diseases characterized by the presence of highly pathogenic immunoglobulins G directed against PF4 and/or PF4/heparin complexes. These antibodies are...
3.
Spiezia L, Kipshidze N
Front Cardiovasc Med
. 2024 Jul;
11:1446992.
PMID: 39011495
No abstract available.
4.
Cadamuro M, Lasagni A, Radu C, Calistri A, Pilan M, Valle C, et al.
J Hepatol
. 2024 Jun;
81(5):872-885.
PMID: 38908437
Background & Aims: The underlying mechanisms and clinical impact of portal microthrombosis in severe COVID-19 are unknown. Intrapulmonary vascular dilation (IPVD)-related hypoxia has been described in severe liver diseases. We...
5.
Zanetto A, Campello E, Spiezia L, Gavasso S, Bulato C, Burra P, et al.
Dig Liver Dis
. 2024 Jun;
56(12):2111-2117.
PMID: 38834381
Introduction: Factor XI (FXI) is associated with thrombosis in patients without liver disease, but it alterations and prognostic value in cirrhosis are uncertain. Patients And Methods: We studied a prospective...
6.
Napolitano A, Toffanin S, Bulato C, Campello E, Simioni P, Spiezia L
Front Cardiovasc Med
. 2024 May;
11:1386733.
PMID: 38803660
Cardiac amyloidosis is a group of diseases characterized by the deposition of amyloid fibers in cardiac tissue. Two forms are mainly reported: light chain (AL) and transthyretin (ATTR) amyloidosis. Among...
7.
Spiezia L, Riva M, Gurrieri C, Campello E, Simioni P
Front Cardiovasc Med
. 2024 Jan;
10:1335296.
PMID: 38259312
The most frequent haematological malignancy associated with acquired hypo/dysfibrinogenemia is multiple myeloma. We present an unusual case of severe haemorrhagic diathesis due to acquired hypofibrinogenemia in a patient with early...
8.
Spiezia L, Campello E, Tormene D, Simioni P
Semin Thromb Hemost
. 2024 Jan;
50(6):866-872.
PMID: 38181816
The incidence of venous thromboembolism (VTE) in the pediatric population has increased more than 10-fold in the last 20 years, as a consequence of the advancement of resuscitation and surgical...
9.
Spiezia L, Campello E, Simioni P, Lumbreras-Marquez M
Thromb Res
. 2023 Dec;
234:21-31.
PMID: 38142487
Background: Several studies have evaluated the possible association between whole blood viscoelastic testing (VET) parameters in patients hospitalized for acute Coronavirus disease 2019 (COVID-19) pneumonia and mortality. A few studies...
10.
Chinellato M, Gasparotto M, Quarta S, Ruvoletto M, Biasiolo A, Filippini F, et al.
Pharmaceuticals (Basel)
. 2023 Oct;
16(10).
PMID: 37895957
In the last decades, studies on the inflammatory signaling pathways in multiple pathological contexts have revealed new targets for novel therapies. Among the family of G-protein-coupled Proteases Activated Receptors, PAR2...